» Articles » PMID: 37232716

Dermal Fibroblasts As the Main Target for Skin Anti-Age Correction Using a Combination of Regenerative Medicine Methods

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2023 May 26
PMID 37232716
Authors
Affiliations
Soon will be listed here.
Abstract

This article includes the data from current studies regarding the pathophysiological mechanisms of skin aging and the regenerative processes occurring in the epidermis and dermis at the molecular and cellular level, mainly, the key role of dermal fibroblasts in skin regeneration. Analyzing these data, the authors proposed the concept of skin anti-age therapy that is based on the correction of age-related skin changes by stimulating regenerative processes at the molecular and cellular level. The main target of the skin anti-age therapy is dermal fibroblasts (DFs). A variant of the cosmetological anti-age program using the combination of laser and cellular methods of regenerative medicine is presented in the paper. The program includes three stages of implementation and defines the tasks and methods of each stage. Thus, laser technologies allow one to remodel the collagen matrix and create favorable conditions for DFs functions, whereas the cultivated autologous dermal fibroblasts replenish the pool of mature DFs decreasing with age and are responsible for the synthesis of components of the dermal extracellular matrix. Finally, the use of autological platelet-rich plasma (PRP) enables to maintenance of the achieved results by stimulating DF function. It has been shown that growth factors/cytokines contained in α-granules of platelets injected into the skin bind to the corresponding transmembrane receptors on the surface of DFs and stimulate their synthetic activity. Thus, the consecutive, step-by-step application of the described methods of regenerative medicine amplifies the effect on the molecular and cellular aging processes and thereby allows one to optimize and prolong the clinical results of skin rejuvenation.

Citing Articles

Extract Modulates Gene Expression Profiles Associated with Antioxidant Defense, Cytoprotection, and Senescence in Human Dermal Fibroblasts: Investigation of Quantitative Gene Expression by qPCR.

Kuhnel H, Seiler M, Feldhofer B, Ebrahimian A, Maurer M Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996851 PMC: 11854148. DOI: 10.3390/cimb47020130.


Cytotoxicity evaluation of microbial sophorolipids and glucolipids using normal human dermal fibroblasts (NHDF) .

Formoso S, Chaleix V, Baccile N, Helary C Toxicol Rep. 2025; 14():101862.

PMID: 39802599 PMC: 11719410. DOI: 10.1016/j.toxrep.2024.101862.


Skin Rejuvenation Using Autologous Cultured Fibroblast Grafting.

Hirose Y, Fujita C, Hyoudou T, Inoue E, Inoue H Cureus. 2025; 16(12):e75405.

PMID: 39781128 PMC: 11710863. DOI: 10.7759/cureus.75405.


Human Skin Fibroblasts as an In Vitro Model Illustrating Changes in Collagen Levels and Skin Cell Migration Under the Influence of Selected Plant Hormones.

Jablonska-Trypuc A, Pankiewicz W, Wolejko E, Sokolowska G, Estevez J, Sogorb M Bioengineering (Basel). 2025; 11(12.

PMID: 39768006 PMC: 11726836. DOI: 10.3390/bioengineering11121188.


Adipose Tissue, Regeneration, and Skin Health: The Next Regenerative Frontier.

Widgerow A Aesthet Surg J Open Forum. 2024; 6:ojae117.

PMID: 39703369 PMC: 11658414. DOI: 10.1093/asjof/ojae117.


References
1.
Moore K, Lemischka I . Stem cells and their niches. Science. 2006; 311(5769):1880-5. DOI: 10.1126/science.1110542. View

2.
Zorina A, Zorin V, Kudlay D, Kopnin P . Age-Related Changes in the Fibroblastic Differon of the Dermis: Role in Skin Aging. Int J Mol Sci. 2022; 23(11). PMC: 9181700. DOI: 10.3390/ijms23116135. View

3.
El Ghalbzouri A, Lamme E, Ponec M . Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res. 2002; 310(2):189-99. DOI: 10.1007/s00441-002-0621-0. View

4.
Kumaran M . Platelet-rich plasma in dermatology: boon or a bane?. Indian J Dermatol Venereol Leprol. 2014; 80(1):5-14. DOI: 10.4103/0378-6323.125467. View

5.
Ramezankhani R, Torabi S, Minaei N, Madani H, Rezaeiani S, Hassani S . Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies. Front Cell Dev Biol. 2021; 8:547653. PMC: 7773756. DOI: 10.3389/fcell.2020.547653. View